Literature DB >> 17351264

A case control study of lung cancer and exposure to chrysotile and amphibole at a slovenian asbestos-cement plant.

M Dodic Fikfak1, D Kriebel, M M Quinn, E A Eisen, D H Wegman.   

Abstract

A lung cancer case-control study was conducted in a Slovenian asbestos-cement factory for which unusually good records of asbestos exposures were available. The cohort consisted of all 6714 workers employed at the Salonit Anhovo factory after 31 December 1946 who worked there for at least one day between 1964 and 1994. Fifty-eight histologically confirmed cases of primary lung cancer and 290 controls were selected from the cohort. Working life exposure histories to amphibole and chrysotile forms of asbestos were estimated separately. Airborne asbestos concentrations were low. For example, the arithmetic mean exposure to all forms of asbestos in the highest exposure period (1947-1971) was 1.2 f/cm(3). Chrysotile asbestos made up about 90% of this exposure (mean 1.1 f/cm(3)), whereas amphibole accounted for 10% (0.1 f/cm(3)). Comparing those above and below the 90 percentile of cumulative exposure, the odds ratios for all asbestos, chrysotile and amphibole were 1.5, 1.6 and 2.0, respectively, but confidence intervals were wide. There are only a few asbestos-lung cancer studies with high-quality exposure data and exposures in this low range. Though imprecise, the findings are important to the ongoing debate about asbestos risks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17351264     DOI: 10.1093/annhyg/mem003

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  9 in total

Review 1.  Molecular understanding of lung cancers-A review.

Authors:  Chinnappan Ravinder Singh; Kandasamy Kathiresan
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

2.  Manganese and extracellular superoxide dismutase polymorphisms and risk for asbestosis.

Authors:  Alenka Franko; Metoda Dodic-Fikfak; Niko Arnerić; Vita Dolzan
Journal:  J Biomed Biotechnol       Date:  2009-07-14

3.  Inducible nitric oxide synthase genetic polymorphism and risk of asbestosis.

Authors:  Alenka Franko; Metoda Dodič-Fikfak; Niko Arnerić; Vita Dolžan
Journal:  J Biomed Biotechnol       Date:  2011-05-24

4.  Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma.

Authors:  Viljem Kovac; Metoda Dodic-Fikfak; Niko Arneric; Vita Dolzan; Alenka Franko
Journal:  Radiol Oncol       Date:  2015-08-21       Impact factor: 2.991

5.  The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma.

Authors:  Alenka Franko; Nika Kotnik; Katja Goricar; Viljem Kovac; Metoda Dodic-Fikfak; Vita Dolzan
Journal:  Radiol Oncol       Date:  2018-01-24       Impact factor: 2.991

6.  The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesothelioma.

Authors:  Kristina Levpuscek; Katja Goricar; Viljem Kovac; Vita Dolzan; Alenka Franko
Journal:  Radiol Oncol       Date:  2019-03-14       Impact factor: 2.991

7.  NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases.

Authors:  Alenka Franko; Katja Goricar; Viljem Kovac; Metoda Dodic-Fikfak; Vita Dolzan
Journal:  J Med Biochem       Date:  2020-01-10       Impact factor: 3.402

8.  The influence of gene-gene and gene-environment interactions on the risk of asbestosis.

Authors:  A Franko; V Dolžan; N Arnerić; M Dodič-Fikfak
Journal:  Biomed Res Int       Date:  2013-07-25       Impact factor: 3.411

9.  Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseases.

Authors:  Katja Goricar; Viljem Kovac; Metoda Dodic-Fikfak; Vita Dolzan; Alenka Franko
Journal:  Radiol Oncol       Date:  2020-03-07       Impact factor: 2.991

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.